These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29745343)

  • 1. Indazole Derivatives: Promising Anti-tumor Agents.
    Wan Y; He S; Li W; Tang Z
    Anticancer Agents Med Chem; 2018; 18(9):1228-1234. PubMed ID: 29745343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.
    El-Damasy AK; Jin H; Seo SH; Bang EK; Keum G
    Eur J Med Chem; 2020 Dec; 207():112710. PubMed ID: 32961435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Development of Indazole-based Anticancer Agents.
    Dong J; Zhang Q; Wang Z; Huang G; Li S
    ChemMedChem; 2018 Aug; 13(15):1490-1507. PubMed ID: 29863292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
    Yang L; Chen Y; He J; Njoya EM; Chen J; Liu S; Xie C; Huang W; Wang F; Wang Z; Li Y; Qian S
    Bioorg Med Chem; 2019 Mar; 27(6):1087-1098. PubMed ID: 30773421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer.
    Zhang S; Chen Y; Tian C; He Y; Tian Z; Wan Y; Liu T
    Curr Med Chem; 2021; 28(9):1775-1795. PubMed ID: 32520674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors.
    Zhang Z; Zhao D; Dai Y; Cheng M; Geng M; Shen J; Ma Y; Ai J; Xiong B
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27782099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of pyrrolo[2,3-g]indazoles as new Pim kinase inhibitors.
    Gavara L; Suchaud V; Nauton L; Théry V; Anizon F; Moreau P
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2298-301. PubMed ID: 23499503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
    Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
    Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.
    Wang HL; Cee VJ; Chavez F; Lanman BA; Reed AB; Wu B; Guerrero N; Lipford JR; Sastri C; Winston J; Andrews KL; Huang X; Lee MR; Mohr C; Xu Y; Zhou Y; Tasker AS
    Bioorg Med Chem Lett; 2015 Feb; 25(4):834-40. PubMed ID: 25597005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indazole derivatives and their therapeutic applications: a patent review (2013-2017).
    Denya I; Malan SF; Joubert J
    Expert Opin Ther Pat; 2018 Jun; 28(6):441-453. PubMed ID: 29718740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H-indazole molecules reduced the activity of human erythrocytes carbonic anhydrase I and II isoenzymes.
    Alim Z
    J Biochem Mol Toxicol; 2018 Sep; 32(9):e22194. PubMed ID: 29984869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer.
    Chen X; Liu Y; Zhang L; Chen D; Dong Z; Zhao C; Liu Z; Xia Q; Wu J; Chen Y; Zheng X; Cai Y
    Eur J Med Chem; 2021 Mar; 214():113219. PubMed ID: 33618175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel 1
    Liu J; Wen Y; Gao L; Gao L; He F; Zhou J; Wang J; Dai R; Chen X; Kang D; Hu L
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):72-84. PubMed ID: 31682465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold.
    Liu J; Peng X; Dai Y; Zhang W; Ren S; Ai J; Geng M; Li Y
    Org Biomol Chem; 2015 Jul; 13(28):7643-54. PubMed ID: 26080733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indazole as a Privileged Scaffold: The Derivatives and their Therapeutic Applications.
    Qin J; Cheng W; Duan YT; Yang H; Yao Y
    Anticancer Agents Med Chem; 2021; 21(7):839-860. PubMed ID: 32819234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 1H-indazole-3-carboxamide derivatives as potent and selective PAK1 inhibitors with anti-tumour migration and invasion activities.
    Zhang M; Fang X; Wang C; Hua Y; Huang C; Wang M; Zhu L; Wang Z; Gao Y; Zhang T; Liu H; Zhang Y; Lu S; Lu T; Chen Y; Li H
    Eur J Med Chem; 2020 Oct; 203():112517. PubMed ID: 32846314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel inhibitors of Aurora A with a 3-(pyrrolopyridin-2-yl)indazole scaffold.
    Song P; Chen M; Ma X; Xu L; Liu T; Zhou Y; Hu Y
    Bioorg Med Chem; 2015 Apr; 23(8):1858-68. PubMed ID: 25771484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amine.
    Shan Y; Dong J; Pan X; Zhang L; Zhang J; Dong Y; Wang M
    Eur J Med Chem; 2015 Nov; 104():139-47. PubMed ID: 26451772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review on phosphatidylinositol-3-kinase (PI3K) and its inhibitors bearing pyrazole or indazole core for cancer therapy.
    Bastos IM; Rebelo S; Silva VLM
    Chem Biol Interact; 2024 Aug; 398():111073. PubMed ID: 38823538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design.
    Chang CF; Lin WH; Ke YY; Lin YS; Wang WC; Chen CH; Kuo PC; Hsu JTA; Uang BJ; Hsieh HP
    Eur J Med Chem; 2016 Nov; 124():186-199. PubMed ID: 27573544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.